JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4226
CALL
Aurinia Pharmaceuticals
AUPH
$2.09B
| $325K | ﹤0.01% |
+50,000
| New | +$332K |
2019 Q1
0 quarters
|
|
|
4227
PUT
Aurinia Pharmaceuticals
AUPH
$2.09B
| $325K | ﹤0.01% |
50,000
| – | – |
2018 Q3
2 quarters
|
|
4228
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.94B
| $325K | ﹤0.01% |
5,044
-465
| -8% | -$28.5K |
2013 Q3
22 quarters
|
|
4229
Travere Therapeutics
TVTX
$5.44B
| $325K | ﹤0.01% |
14,357
+74
| +0.5% | +$1.64K |
2016 Q4
9 quarters
|
|
4230
Hecla Mining
HL
$11.4B
| $322K | ﹤0.01% |
140,087
-54,317
| -28% | -$137K |
2015 Q4
13 quarters
|
|
4231
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.09B
| $322K | ﹤0.01% |
6,467
+3,780
| +141% | +$187K |
2015 Q1
16 quarters
|
|
4232
Amplify AI Powered Equity ETF
AIEQ
$115M
| $321K | ﹤0.01% |
12,400
-18,963
| -60% | -$471K |
2018 Q4
1 quarter
|
|
|
BRSP
4233
BrightSpire Capital
BRSP
$477M
| $320K | ﹤0.01% |
20,405
-1,052
| -5% | -$17.3K |
2018 Q2
3 quarters
|
|
|
CBL
4234
DELISTED
CBL& Associates Properties, Inc.
CBL
| $320K | ﹤0.01% |
206,340
-646,219
| -76% | -$1.38M |
2013 Q2
23 quarters
|
|
|
XELA
4235
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $319K | ﹤0.01% |
8
-2
| -20% | -$91.9K |
2017 Q3
6 quarters
|
|
|
CSII
4236
DELISTED
Cardiovascular Systems, Inc.
CSII
| $318K | ﹤0.01% |
8,230
-423
| -5% | -$14.3K |
2016 Q2
11 quarters
|
|
4237
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.71B
| $315K | ﹤0.01% |
10,972
| – | – |
2016 Q2
11 quarters
|
|
|
MDSO
4238
CALL
DELISTED
Medidata Solutions, Inc.
MDSO
| $315K | ﹤0.01% |
+4,300
| New | +$310K |
2019 Q1
0 quarters
|
|
4239
Invesco Taxable Municipal Bond ETF
BAB
$834M
| $314K | ﹤0.01% |
10,301
+2,071
| +25% | +$61.6K |
2015 Q4
13 quarters
|
|
4240
Lennar Class B
LEN.B
$17.5B
| $314K | ﹤0.01% |
8,458
+24
| +0.3% | +$857 |
2013 Q2
23 quarters
|
|
4241
ANI Pharmaceuticals
ANIP
$1.67B
| $313K | ﹤0.01% |
4,443
-57,599
| -93% | -$3.39M |
2016 Q1
12 quarters
|
|
4242
Oil-Dri
ODC
$1.27B
| $313K | ﹤0.01% |
20,140
+3,438
| +21% | +$48.9K |
2017 Q4
5 quarters
|
|
|
OBSV
4243
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $313K | ﹤0.01% |
24,482
+15,037
| +159% | +$194K |
2018 Q4
1 quarter
|
|
4244
LifeVantage
LFVN
$75.9M
| $312K | ﹤0.01% |
21,835
+16,242
| +290% | +$236K |
2016 Q4
9 quarters
|
|
4245
PUT
Targa Resources
TRGP
$61.6B
| $312K | ﹤0.01% |
7,500
| – | – |
2018 Q4
1 quarter
|
|
|
VVUS
4246
DELISTED
Vivus Inc
VVUS
| $312K | ﹤0.01% |
74,368
+50,945
| +217% | +$227K |
2018 Q4
1 quarter
|
|
4247
Harmonic Inc
HLIT
$1.22B
| $311K | ﹤0.01% |
57,391
-62,691
| -52% | -$332K |
2013 Q2
23 quarters
|
|
4248
iShares New York Muni Bond ETF
NYF
$1.53B
| $310K | ﹤0.01% |
5,546
+4,796
| +639% | +$264K |
2015 Q4
13 quarters
|
|
|
VOXX
4249
DELISTED
VOXX International Corporation Class A
VOXX
| $310K | ﹤0.01% |
67,113
-19,713
| -23% | -$96.4K |
2017 Q4
5 quarters
|
|
4250
VanEck Retail ETF
RTH
$235M
| $309K | ﹤0.01% |
2,951
-98
| -3% | -$9.87K |
2017 Q4
5 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.